Frontiers Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade
![Frontiers Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade](https://www.frontiersin.org/files/MyHome%20Article%20Library/1198551/1198551_Thumb_400.jpg)
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-023-01471-y/MediaObjects/41392_2023_1471_Fig4_HTML.png)
T cells in health and disease Signal Transduction and Targeted
![](https://www.science.org/cms/10.1126/science.abn5647/asset/af8b5cb3-6b20-47c7-8aa5-c51a81712d88/assets/images/large/science.abn5647-f6.jpg)
Enhanced T cell effector activity by targeting the Mediator kinase
![](https://ars.els-cdn.com/content/image/1-s2.0-S0092867421000659-fx1.jpg)
Inhibitory CD161 receptor identified in glioma-infiltrating T
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32567-8/MediaObjects/41467_2022_32567_Fig1_HTML.png)
Temporally restricted activation of IFNβ signaling underlies
![](https://ars.els-cdn.com/content/image/1-s2.0-S0092867422011928-gr5.jpg)
The primordial differentiation of tumor-specific memory CD8+ T
![](https://iiif.elifesciences.org/lax:76586%2Felife-76586-fig7-v3.tif/full/,1500/0/default.jpg)
Longitudinal analysis of invariant natural killer T cell
![](https://www.future-science.com/cms/10.4155/fsoa-2016-0095/asset/images/medium/figure1.gif)
The development of T cells from stem cells in mice and humans
![](https://www.frontiersin.org/files/Articles/1104771/fimmu-14-1104771-HTML/image_m/fimmu-14-1104771-g004.jpg)
Frontiers T-cell exhaustion and stemness in antitumor immunity
![](https://pubs.acs.org/cms/10.1021/acssynbio.1c00256/asset/images/medium/sb1c00256_0004.gif)
Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40779-023-00496-2/MediaObjects/40779_2023_496_Fig2_HTML.png)
Targeting the epigenome to reinvigorate T cells for cancer